Used in peptide synthesis as a chiral building block for the preparation of biologically active compounds. Its structure allows for selective coupling reactions, making it valuable in the development of pharmaceuticals, particularly those targeting central nervous system disorders and protease inhibitors. The fluorenylmethyloxycarbonyl (Fmoc) group enables easy monitoring of reaction progress due to its UV activity, and it is commonly used in solid-phase peptide synthesis. The presence of the 3,4-dichlorophenyl moiety can enhance binding affinity in receptor-targeted molecules, making this compound useful in structure-activity relationship (SAR) studies.